Enisamium iodide for influenza and Covid 19

RNA virus image: Uploaded a work by Aartjan J. W. te Velthuis from https://link.springer.com/article/10.1007/s00018-014-1695-z

This video discusses a little-known drug, enisamium iodide, that is used to treat influenza and other viral illnesses and proposes an explanation for its efficacy. It draws on studies that show the drug is effective at inhibiting the influenza virus and the SARS-CoV-2 virus, rendering it an exciting prospect for the treatment of select viral illnesses, including Covid-19. Viewers are given an update on the treatment of influenza and an insight into the problems we face with drug resistance in the fight against influenza. Enisamium iodide has undergone clinical trials and has been found experimentally to inhibit the production of viral RNA and viral proteins. The mechanisms by which enisamium iodide exerts its antiviral effect differentiate it from the antivirals in current use, making it a likely candidate for more widespread employment. Viewers will familiarize themselves with this enigmatic drug and in the process develop insight into a drug that in the future is likely to play a more meaningful role in the treatment of influenza and possibly Covid-19.

Chapters

0:00 Introduction
0:25 Influenza drugs
0:36 M2 inhibitors
1:04 Neuraminidase inhibitors
2:10 RNA polymerase inhibitors
2:57 Influenza vaccines
3:48 Enisamiun iodide
4:40 Enisamium mechanism of action
6:12 Enisamium and Covid-19
6:52 Conclusion